Imatinib mesylate at therapeutic doses has no impact on folliculogenesis or spermatogenesis in a leukaemic mouse model

Abl Protein-Tyrosine Kinase Inhibitor STI571 Inhibits In Vitro Signal Transduction Mediated by c-Kit and Platelet-Derived Growth Factor Receptors

Elisabeth Buchdunger, Catherine L. Cioffi, Norman M. Law et al. · Journal of Pharmacology and Experimental Therapeutics · 2000 · 1.3K citations

Medicine, Oncology, Pharmacology +15

Inhibition of the Abl protein-tyrosine kinase in vitro and in vivo by a 2-phenylaminopyrimidine derivative.

Elisabeth Buchdunger, J. Zimmermann, Helmut Mett et al. · PubMed · 1996 · 1.1K citations

Life Sciences, Molecular Biology, Pharmacology +17

Six-year follow-up of patients receiving imatinib for the first-line treatment of chronic myeloid leukemia

Andreas Hochhaus, S G O'Brien, François Guilhot et al. · Leukemia · 2009 · 845 citations

Medicine, Hematology, Oncology +5

The effects of imatinib on pregnancy outcome

Seonaid Pye, Jörge E. Cortes, Patricia Ault et al. · Blood · 2008 · 392 citations

Medicine, Obstetrics, Pharmacotherapy +8

Inhibition of the c-Abl–TAp63 pathway protects mouse oocytes from chemotherapy-induced death

Stefania Gonfloni, Lucia Di Tella, Sara Caldarola et al. · Nature Medicine · 2009 · 350 citations

Life Sciences, Cell Biology, Oncology +14